Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: (NCT02070523) | Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. | 2013-12-01 |
Track Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.